Shopping Cart
Remove All
Your shopping cart is currently empty
TTK-IN-5
Catalog No. T214254 Copy Product Info
🥰Excellent
TTK-IN-5 is an orally active and selective covalent threonine tyrosine kinase (TTK) inhibitor with an IC50 of 8.918 nM. It demonstrates antiproliferative activity against several cell lines, including MDA-MB-231, A2780, HCT116, HCC1569, and MKN1, with IC50 values of 0.113 μM, 0.476 μM, 3.136 μM, 3.649 μM, and 1.856 μM, respectively. In xenograft mouse models using A2780 and MDA-MB-231, TTK-IN-5 effectively inhibits tumor growth without significant toxicity. TTK-IN-5 is applicable in research on cancers such as breast and ovarian cancer.
TTK-IN-5
Copy Product Info🥰Excellent
Catalog No. T214254
TTK-IN-5 is an orally active and selective covalent threonine tyrosine kinase (TTK) inhibitor with an IC50 of 8.918 nM. It demonstrates antiproliferative activity against several cell lines, including MDA-MB-231, A2780, HCT116, HCC1569, and MKN1, with IC50 values of 0.113 μM, 0.476 μM, 3.136 μM, 3.649 μM, and 1.856 μM, respectively. In xenograft mouse models using A2780 and MDA-MB-231, TTK-IN-5 effectively inhibits tumor growth without significant toxicity. TTK-IN-5 is applicable in research on cancers such as breast and ovarian cancer.
TTK-IN-5
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | TTK-IN-5 is an orally active and selective covalent threonine tyrosine kinase (TTK) inhibitor with an IC50 of 8.918 nM. It demonstrates antiproliferative activity against several cell lines, including MDA-MB-231, A2780, HCT116, HCC1569, and MKN1, with IC50 values of 0.113 μM, 0.476 μM, 3.136 μM, 3.649 μM, and 1.856 μM, respectively. In xenograft mouse models using A2780 and MDA-MB-231, TTK-IN-5 effectively inhibits tumor growth without significant toxicity. TTK-IN-5 is applicable in research on cancers such as breast and ovarian cancer. |
| In vitro | TTK-IN-5 (Compound 19) demonstrates potent and highly selective inhibitory activity against threonine tyrosine kinase (TTK), achieving an inhibition rate of up to 98.99% (IC 50 = 8.918 nM). At a concentration of 5 μM over 12 hours, TTK-IN-5 forms a strong interaction and binds tightly to TTK. |
| In vivo | TTK-IN-5 (Compound 19) administered at doses of 7.5 and 15 mg/kg via intravenous injection twice weekly for 21 days leads to significant tumor growth inhibition with low toxicity in MDA-MB-231 xenograft mouse models. Additionally, TTK-IN-5 at 30 mg/kg given orally once daily for 21 days effectively inhibits tumor growth in A2780 xenograft mouse models. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Citations
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy TTK-IN-5 | purchase TTK-IN-5 | TTK-IN-5 cost | order TTK-IN-5 | TTK-IN-5 in vivo | TTK-IN-5 in vitro
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.